Biofrontera Inc. (NASDAQ: BFRI) Announces Upcoming Financial Results and Conference Call

March 9, 2026

Market Overview Biofrontera Inc. (NASDAQ: BFRI), a biopharmaceutical firm focused on photodynamic therapy products, is preparing to release its financial performance for the fourth quarter and the full fiscal year ending December 31, 2025. The announcement comes as investors and market participants await insights into the company’s year-end results amid evolving market conditions in the biopharmaceutical sector. Shares of Biofrontera Inc. have experienced fluctuations influenced by broader industry trends and…

Read More >>